Segment, Customer and Geographical Reporting (Tables)

9 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended June 30, 2014 and 2013 is summarized below:

Results of Operations for the Three Months Ended June 30,
2014
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	5,460,853	$	5,172,217	$	-	$	7,457	$	10,640,527
Gross Profit		2,121,495		1,778,695		-		7,457		3,907,647
Impairment of goodwill		-		-		-		-		-
Operating Income (Loss)		64,007		224,705		39,983		(172,509)		156,186
Depreciation and Amortization		70,149		189,381		-		15,000		274,530
Capital expenditures		-		1,937,479		-		-		1,937,479
Intangibles, Net		307,118		893,062		-		133,333		1,333,513
Goodwill		4,938,625		1,393,771		-		-		6,332,396
Total Assets	$	9,451,010	$	16,053,222	$	335,290	$	632,094	$	26,471,616

Results of Operations for the Three Months Ended June 30,
2013
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	5,933,085	$	3,860,648	$	1,498,609	$	30,000	$	11,322,342
Gross Profit		2,514,235		1,372,490		783,225		30,000		4,699,950
Impairment of goodwill & long-lived assets		-		-		-		-		-
Operating Income (Loss)		22,869		25,402		(48,219)		(215,559)		(215,507)
Depreciation and Amortization		88,770		191,741		163,715		15,000		459,226
Capital expenditures		-		206,898		-		-		206,898
Intangibles, Net		332,800		848,046		2,230,334		194,997		3,606,177
Goodwill		4,938,625		1,197,503		-		-		6,136,128
Total Assets	$	13,562,650	$	8,780,459	$	5,142,707	$	262,955	$	27,748,771

The Company’s segment information for the nine months ended June 30, 2014 and 2013 is summarized below:

Results of Operations for the Nine Months Ended June 30,
2014
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	16,915,355	$	14,059,393	$	772,578	$	11,186	$	31,758,512
Gross Profit		7,092,752		5,295,215		317,908		11,186		12,717,061
Impairment of goodwill		-		-		-		-		-
Operating Income (Loss)		654,339		1,145,249		1,006,161		(568,120)		2,237,629
Depreciation and Amortization		209,645		550,989		2,003		46,666		809,303
Capital expenditures		12,028		2,606,365		-		-		2,618,393
Intangibles, Net		307,118		893,062		-		133,333		1,333,513
Goodwill		4,938,625		1,393,771		-		-		6,332,396
Total Assets	$	9,451,010	$	16,053,222	$	335,290	$	632,094	$	26,471,616

Results of Operations for the Nine Months Ended June 30,
2013
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	16,331,775	$	12,044,354	$	3,796,967	$	187,051	$	32,360,147
Gross Profit		7,376,158		4,434,381		1,850,127		187,051		13,847,717
Impairment of goodwill & long-lived assets		-		-		6,763,072		-		6,763,072
Operating Income (Loss)		254,278		413,414		(7,774,714)		(547,786)		(7,654,808)
Depreciation and Amortization		231,189		562,065		491,147		45,000		1,329,401
Capital expenditures		(1,095)		416,580		7,092		-		422,577
Intangibles, Net		332,800		848,046		2,230,334		194,997		3,606,177
Goodwill		4,938,625		1,197,503		-		-		6,136,128
Total Assets	$	13,562,650	$	8,780,459	$	5,142,707	$	262,955	$	27,748,771

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended June 30, 2014 and 2013 are as follows:

	Three Months Ended					Three Months Ended
	June 30, 2014					June 30, 2013
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	8,254,373		78	%	$	9,426,542		83	%
Europe		688,855		6	%		975,941		9	%
Other		1,697,299		16	%		919,859		8	%
	$	10,640,527		100	%	$	11,322,342		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the nine months ended June 30, 2014 and 2013 are as follows:

	Nine Months Ended				Nine Months Ended
	June 30, 2014				June 30, 2013
Geographic Location	Revenue		% of Total		Revenue		% of Total
United States	$	25,783,653	81	%	$	26,493,062	82	%
Europe		2,363,255	8	%		2,711,944	8	%
Other		3,611,604	11	%		3,155,141	10	%
	$	31,758,512	100	%	$	32,360,147	100	%